Medscape Medical NewsAll articles

YSIO MAX

SIEMENS MEDICAL SOLUTIONS USA, INC. • Radiology • 01/24/2014

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The Ysio Max is an advanced modular radiographic X-ray system designed for comprehensive diagnostic imaging across various patient demographics and clinical applications, including minor interventions. It utilizes new generation digital and wireless detectors, alongside innovative system control software with features like FAST and AIM, to enhance image acquisition flexibility and improve operational workflow efficiency in medical settings.

Summary

The Ysio Max is a modular radiographic X-ray system designed for use in hospitals, clinics, and medical practices. It facilitates radiographic and tomographic exposures of the entire body, including the skull, chest, abdomen, and extremities, catering to pediatric, adult, and bariatric patients. The system can also be employed for intravenous procedures, minor interventions such as biopsies and punctures, and in emergency or trauma settings. It generates diagnostic images by converting X-rays into electronic signals using integrated or portable digital detectors, and is also compatible with conventional film/screen or Computed Radiography (CR) cassettes. Exposures can be performed with patients in sitting, standing, or prone positions, though the system is not intended for mammography. The Ysio Max builds upon its predicate device by incorporating several technological advancements focused on improving image acquisition and operational efficiency. These include a new generation of Trixell digital detectors, offering one integrated (43x43cm) and two wireless options (35x43cm and 24x30cm MAX Mini), providing greater flexibility and suitability for varied anatomical imaging. The system introduces enhanced control software featuring Free Axis Simultaneous Travel (FAST) across up to six axes and Artificial Intelligence Mapping (AIM) to optimize the path and speed of equipment positioning, thereby streamlining workflow. Further enhancements include the optional integration of Riverain ClearRead software for improved soft tissue visualization in digital chest X-rays and ergonomic updates such as new handgrips for the Bucky wall stand.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Radiographic X-rayTomographic exposuresDigital detectorsWireless detectorsModular systemSystem control softwareFree Axis Simultaneous Travel (FAST)Artificial Intelligence Mapping (AIM)Riverain ClearReadBucky wall stand

Device Metadata

Submission Number
K133259
Company
SIEMENS MEDICAL SOLUTIONS USA, INC.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
acquisition guidance

Relevant Clinical Questions

  • Q1. How does the 'Artificial Intelligence Mapping (AIM)' feature quantitatively improve workflow efficiency and patient throughput compared to systems without it?; What is the specific impact of the new Trixell detector generation on image quality (e.g., spatial resolution, contrast-to-noise ratio) and radiation dose reduction compared to the previous detectors?; What are the practical advantages and limitations of using the MAX Mini (24x30cm) wireless detector for specific anatomical regions like pediatric imaging or extremities, beyond just being 'optimal for smaller images'?; Given its capability for 'small interventions,' what specific safety features or imaging protocols are recommended when using the Ysio Max for procedures like biopsies or punctures?; How does the integration of Riverain ClearRead as an optional configuration affect the overall image processing time and diagnostic confidence for chest X-rays specifically?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials
- Not detected
SaaSBOMSoftware-as-a-Service Bill of Materials(wireless)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(configuration, operational)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SaaSBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, ML-BOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
YSIO MAX - SIEMENS MEDICAL SOLUTIONS USA, INC. | ESL FDA AI Device Intelligence